StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.75−0.26 (-8.80%)

Close on Nov 18, 2026Market cap $53.09MP/E –Yield –

Corbus Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Corbus Pharmaceuticals's revenue for the twelve months ending Dec 31, 2022 was $0, down 100.0% year over year. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $36.14M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$881.71K-77.6%
FY2020Dec 31, 2020$3.94M-89.1%
FY2019Dec 31, 2019$36.14M+649.5%
FY2018Dec 31, 2018$4.82M+97.6%
FY2017Dec 31, 2017$2.44M+27.7%
FY2016Dec 31, 2016$1.91M+194.8%
FY2015Dec 31, 2015$648.38K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$0-100.0%
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$97.32K-92.1%
Q2 FY2021Jun 30, 2021$136.56K-52.3%
Q1 FY2021Mar 31, 2021$647.82K-63.2%
Q4 FY2020Dec 31, 2020$658.20K-74.4%
Q3 FY2020Sep 30, 2020$1.23M-52.5%
Q2 FY2020Jun 30, 2020$286.35K-99.0%
Q1 FY2020Mar 31, 2020$1.76M-6.6%
Q4 FY2019Dec 31, 2019$2.57M+33.5%
Q3 FY2019Sep 30, 2019$2.59M+137.4%
Q2 FY2019Jun 30, 2019$29.09M+3308.3%
Q1 FY2019Mar 31, 2019$1.89M+98.4%
Q4 FY2018Dec 31, 2018$1.93M–
Q3 FY2018Sep 30, 2018$1.09M+37.0%
Q2 FY2018Jun 30, 2018$853.65K+143.8%
Q1 FY2018Mar 31, 2018$950.44K-26.5%
Q4 FY2017Dec 31, 2017$0-100.0%
Q3 FY2017Sep 30, 2017$796.31K+7.2%
Q2 FY2017Jun 30, 2017$350.19K–
Q1 FY2017Mar 31, 2017$1.29M–
Q4 FY2016Dec 31, 2016$375.67K–
Q3 FY2016Sep 30, 2016$742.56K–

More Corbus Pharmaceuticals figures

See a number that looks wrong?